Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557)
Kaydedildi:
| Yayımlandı: | Alzheimer's & Dementia vol. 21 (Dec 1, 2025) |
|---|---|
| Yazar: | |
| Diğer Yazarlar: | , , |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
|
| Konular: | |
| Online Erişim: | Citation/Abstract Full Text - PDF |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
İlk yorumlayan siz olun!